Cargando…
Glycosylation and the cystic fibrosis transmembrane conductance regulator
The cystic fibrosis transmembrane conductance regulator (CFTR) has been known for the past 11 years to be a membrane glycoprotein with chloride channel activity. Only recently has the glycosylation of CFTR been examined in detail, by O'Riordan et al in Glycobiology. Using cells that overexpress...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59516/ https://www.ncbi.nlm.nih.gov/pubmed/11686896 http://dx.doi.org/10.1186/rr69 |
_version_ | 1782120062528782336 |
---|---|
author | Scanlin, Thomas F Glick, Mary Catherine |
author_facet | Scanlin, Thomas F Glick, Mary Catherine |
author_sort | Scanlin, Thomas F |
collection | PubMed |
description | The cystic fibrosis transmembrane conductance regulator (CFTR) has been known for the past 11 years to be a membrane glycoprotein with chloride channel activity. Only recently has the glycosylation of CFTR been examined in detail, by O'Riordan et al in Glycobiology. Using cells that overexpress wild-type (wt)CFTR, the presence of polylactosamine was noted on the fully glycosylated form of CFTR. In the present commentary the results of that work are discussed in relation to the glycosylation phenotype of cystic fibrosis (CF), and the cellular localization and processing of ΔF508 CFTR. The significance of the glycosylation will be known when endogenous CFTR from primary human tissue is examined. |
format | Text |
id | pubmed-59516 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2001 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-595162001-11-06 Glycosylation and the cystic fibrosis transmembrane conductance regulator Scanlin, Thomas F Glick, Mary Catherine Respir Res Commentary The cystic fibrosis transmembrane conductance regulator (CFTR) has been known for the past 11 years to be a membrane glycoprotein with chloride channel activity. Only recently has the glycosylation of CFTR been examined in detail, by O'Riordan et al in Glycobiology. Using cells that overexpress wild-type (wt)CFTR, the presence of polylactosamine was noted on the fully glycosylated form of CFTR. In the present commentary the results of that work are discussed in relation to the glycosylation phenotype of cystic fibrosis (CF), and the cellular localization and processing of ΔF508 CFTR. The significance of the glycosylation will be known when endogenous CFTR from primary human tissue is examined. BioMed Central 2001 2001-08-07 /pmc/articles/PMC59516/ /pubmed/11686896 http://dx.doi.org/10.1186/rr69 Text en Copyright © 2001 BioMed Central Ltd |
spellingShingle | Commentary Scanlin, Thomas F Glick, Mary Catherine Glycosylation and the cystic fibrosis transmembrane conductance regulator |
title | Glycosylation and the cystic fibrosis transmembrane conductance regulator |
title_full | Glycosylation and the cystic fibrosis transmembrane conductance regulator |
title_fullStr | Glycosylation and the cystic fibrosis transmembrane conductance regulator |
title_full_unstemmed | Glycosylation and the cystic fibrosis transmembrane conductance regulator |
title_short | Glycosylation and the cystic fibrosis transmembrane conductance regulator |
title_sort | glycosylation and the cystic fibrosis transmembrane conductance regulator |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59516/ https://www.ncbi.nlm.nih.gov/pubmed/11686896 http://dx.doi.org/10.1186/rr69 |
work_keys_str_mv | AT scanlinthomasf glycosylationandthecysticfibrosistransmembraneconductanceregulator AT glickmarycatherine glycosylationandthecysticfibrosistransmembraneconductanceregulator |